BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38182489)

  • 1. Αlpha-thalassemia: A practical overview.
    Musallam KM; Cappellini MD; Coates TD; Kuo KHM; Al-Samkari H; Sheth S; Viprakasit V; Taher AT
    Blood Rev; 2024 Mar; 64():101165. PubMed ID: 38182489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha and beta thalassemia.
    Muncie HL; Campbell J
    Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta Thalassemia: Monitoring and New Treatment Approaches.
    Khandros E; Kwiatkowski JL
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):339-353. PubMed ID: 31030806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha- and Beta-thalassemia: Rapid Evidence Review.
    Baird DC; Batten SH; Sparks SK
    Am Fam Physician; 2022 Mar; 105(3):272-280. PubMed ID: 35289581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD; Motta I
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
    Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat non-transfusion-dependent β-thalassemia.
    Saliba AN; Musallam KM; Taher AT
    Blood; 2023 Sep; 142(11):949-960. PubMed ID: 37478396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions.
    Kalleda N; Flace A; Altermatt P; Ingoglia G; Doucerain C; Nyffenegger N; Dürrenberger F; Manolova V
    Haematologica; 2023 Oct; 108(10):2703-2714. PubMed ID: 37165842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical transfusion-dependent humanized mouse model of beta thalassemia major.
    Huo Y; McConnell SC; Ryan TM
    Blood; 2009 May; 113(19):4763-70. PubMed ID: 19258591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation.
    Motta I; Bou-Fakhredin R; Taher AT; Cappellini MD
    Drugs; 2020 Jul; 80(11):1053-1063. PubMed ID: 32557398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Therapies in β-Thalassemia.
    Bou-Fakhredin R; Kuo KHM; Taher AT
    Hematol Oncol Clin North Am; 2023 Apr; 37(2):449-462. PubMed ID: 36907614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
    Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
    Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia major.
    Casu C; Chessa R; Liu A; Gupta R; Drakesmith H; Fleming R; Ginzburg YZ; MacDonald B; Rivella S
    Haematologica; 2020 Jul; 105(7):1835-1844. PubMed ID: 31582543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-thalassemia: is cure still a dream?
    Hodroj MH; Akiki N; Bou-Fakhredin R; Taher AT
    Minerva Med; 2023 Dec; 114(6):850-860. PubMed ID: 37534831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Thalassemia.
    Origa R
    Genet Med; 2017 Jun; 19(6):609-619. PubMed ID: 27811859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical manifestations of α-thalassemia.
    Vichinsky EP
    Cold Spring Harb Perspect Med; 2013 May; 3(5):a011742. PubMed ID: 23543077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of alpha-thalassemia.
    Vichinsky E
    Blood Rev; 2012 Apr; 26 Suppl 1():S31-4. PubMed ID: 22631041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2021 update on clinical trials in β-thalassemia.
    Musallam KM; Bou-Fakhredin R; Cappellini MD; Taher AT
    Am J Hematol; 2021 Nov; 96(11):1518-1531. PubMed ID: 34347889
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.